デフォルト表紙
市場調査レポート
商品コード
1743914

禁煙補助薬市場-世界の産業規模、シェア、動向、機会、予測、製品別、エンドユーザー別、地域別、競合別、2020-2030年

Smoking Cessation Aids Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-User, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 183 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.10円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

禁煙補助薬市場-世界の産業規模、シェア、動向、機会、予測、製品別、エンドユーザー別、地域別、競合別、2020-2030年
出版日: 2025年06月06日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

禁煙補助薬の世界市場規模は2024年に230億2,000万米ドルとなり、2030年までCAGR 7.28％で力強い成長が予測されています。

この市場はヘルスケアの重要な一部であり、様々な製品やサービスを通じて禁煙を支援することに焦点を当てています。タバコの使用に伴う健康リスクに対する認識が高まるにつれ、禁煙補助薬の採用が増加しています。市場には、ニコチン代替療法（NRT）、処方薬、電子タバコ、デジタル介入が含まれます。ドイツ初のジェネリック・ニコチン・チューインガムのような革新的なソリューションの導入や、Achieve Life Sciences社のORCA-V1試験のような有望な臨床結果は、利用しやすく効果的な禁煙補助薬が重視されるようになっていることを裏付けています。技術の進歩と消費者の健康意識の高まりが、個別化された治療法の開発と普及を後押ししており、市場は今後数年間で着実に拡大するものと思われます。

市場概要
予測期間 2026-2030
市場規模：2024年 230億2,000万米ドル
市場規模：2030年 348億1,000万米ドル
CAGR：2025年～2030年 7.28%
急成長セグメント オンラインチャンネル
最大市場 北米

市場促進要因

健康に対する意識の高まり

主な市場課題

有効性の認識と安全性への懸念

主要市場動向

デジタル禁煙ソリューションの台頭

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の禁煙補助薬市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別（ニコチン置換療法、医薬品、電子タバコ、その他）
    • エンドユーザー別（病院薬局、オンラインチャネル、小売薬局、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米の禁煙補助薬市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の禁煙補助薬市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋地域の禁煙補助薬市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の禁煙補助薬市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの禁煙補助薬市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 世界の禁煙補助薬市場：SWOT分析

第14章 競合情勢

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16215

The Global Smoking Cessation Aids Market was valued at USD 23.02 billion in 2024 and is projected to witness robust growth at a CAGR of 7.28% through 2030. This market is a vital part of the healthcare landscape, focused on helping individuals quit smoking through a range of products and services. As awareness of the health risks associated with tobacco use increases, there is rising adoption of smoking cessation aids. The market includes nicotine replacement therapies (NRT), prescription medications, electronic cigarettes, and digital interventions. The introduction of innovative solutions, such as Germany's first generic nicotine chewing gum and promising clinical results from trials like Achieve Life Sciences' ORCA-V1 study, underscores the growing emphasis on accessible and effective quit-smoking aids. Technological advances and growing consumer health consciousness are driving the development and uptake of personalized treatment options, positioning the market for steady expansion in the coming years.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 23.02 Billion
Market Size 2030USD 34.81 Billion
CAGR 2025-20307.28%
Fastest Growing SegmentOnline Channels
Largest MarketNorth America

Key Market Drivers

Rising Awareness and Health Concerns

Increasing awareness of the health hazards linked to tobacco use is a major factor propelling the global smoking cessation aids market. Public understanding of the correlation between smoking and life-threatening diseases-such as cardiovascular disorders, respiratory illnesses, and cancers-has significantly grown, motivating individuals to seek out cessation support. Furthermore, the global emphasis on personal health and well-being is encouraging more people to take proactive steps toward quitting. As individuals prioritize longevity and a higher quality of life, demand for effective, science-backed smoking cessation products continues to rise. This heightened health consciousness is translating into increased usage of both over-the-counter and prescribed quit-smoking aids.

Key Market Challenges

Perceived Effectiveness and Safety Concerns

A notable challenge in the smoking cessation aids market is public skepticism surrounding the effectiveness and safety of available products. Some consumers doubt whether these aids genuinely improve quit rates or worry about potential side effects, particularly with pharmaceutical interventions. This hesitation can discourage individuals from using cessation aids altogether, opting instead for unsupported or self-guided attempts to quit. Addressing these concerns by reinforcing evidence-based outcomes and educating users on proper usage is critical for increasing adoption and trust in cessation therapies.

Key Market Trends

Rise in Digital Smoking Cessation Solutions

A growing trend in the smoking cessation landscape is the adoption of digital tools and services. Mobile apps, online coaching platforms, and telehealth services are becoming increasingly popular for their convenience, accessibility, and personalized features. These platforms offer real-time support, behavioral tracking, and adaptive quit plans that cater to individual needs. The integration of digital solutions reflects the broader shift in healthcare toward technology-driven interventions, opening new opportunities for engagement and treatment effectiveness in the smoking cessation market.

Key Market Players

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

Report Scope:

In this report, the Global Smoking Cessation Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Smoking Cessation Aids Market, By Product:

  • Nicotine Replacement Therapy
  • Drugs
  • Electronic Cigarettes
  • Others

Smoking Cessation Aids Market, By End-User:

  • Hospital Pharmacies
  • Online Channels
  • Retail Pharmacies
  • Other

Smoking Cessation Aids Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Smoking Cessation Aids Market.

Available Customizations:

Global Smoking Cessation Aids market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Smoking Cessation Aids Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, Others)
    • 5.2.2. By End-User (Hospital Pharmacies, Online Channels, Retail Pharmacies, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Smoking Cessation Aids Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Smoking Cessation Aids Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Smoking Cessation Aids Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Smoking Cessation Aids Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-User

7. Europe Smoking Cessation Aids Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Smoking Cessation Aids Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-User
    • 7.3.2. United Kingdom Smoking Cessation Aids Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-User
    • 7.3.3. Italy Smoking Cessation Aids Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-User
    • 7.3.4. France Smoking Cessation Aids Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Smoking Cessation Aids Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-User

8. Asia-Pacific Smoking Cessation Aids Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Smoking Cessation Aids Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Smoking Cessation Aids Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Smoking Cessation Aids Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Smoking Cessation Aids Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Smoking Cessation Aids Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-User

9. South America Smoking Cessation Aids Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Smoking Cessation Aids Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Smoking Cessation Aids Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Smoking Cessation Aids Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Smoking Cessation Aids Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Smoking Cessation Aids Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Smoking Cessation Aids Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Smoking Cessation Aids Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Smoking Cessation Aids Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. End-User Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. GlaxoSmithKline PLC
  • 14.3. Hoffmann-La Roche AG
  • 14.4. Novartis AG
  • 14.5. Johnson and Johnson
  • 14.6. Bayer AG
  • 14.7. Cipla Ltd
  • 14.8. Takeda Pharmaceuticals Co. Ltd
  • 14.9. British American Tobacco PLC
  • 14.10. Kimree Technology Inc
  • 14.11. Imperial Tobacco Ltd

15. Strategic Recommendations

16. About Us & Disclaimer